Iterative Approach to the Discovery of Novel Degarelix Analogues: Substitutions at Positions 3, 7, and 8. Part II
Authors:
- 28 June 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (15) , 4851-4860
Abstract
Degarelix (FE200486, Ac-d-2Nal1-d-4Cpa2-d-3Pal3-Ser4-4Aph(l-Hor)5-d-4Aph(Cbm)6-Leu7-ILys8-Pro9-d-Ala10-NH2) is a potent and very long acting antagonist of gonadotropin-releasing hormone (GnRH) after subcutaneous administration in mammals including humans. Analogues of degarelix were synthesized, characterized, and screened for the antagonism of GnRH-induced response in a reporter gene assay in HEK-293 cells expressing the human GnRH receptor. The duration of action was also determined in the castrated male rat assay to measure the extent (efficacy and duration of action) of inhibition of luteinizing hormone (LH) release. Structurally, this series of analogues has novel substitutions at positions 3, 7, and 8 and Nα-methylation at positions 6, 7, and 8 in the structure of degarelix. These substitutions were designed to probe the spatial limitations of the receptor's cavity and to map the steric and ionic boundaries. Some functional groups were introduced that were hypothesized to influence the phamacokinetic properties of the analogues such as bioavailability, solubility, intra- or intermolecular hydrogen bond forming capacity, and ability to bind carrier proteins. Substitutions at positions 3 ([Nβ-(2-pyridyl-methyl)d-Dap3]degarelix, IC50 = 2.71 nM) (5), 7 ([Pra7]degarelix, IC50 = 2.11 nM) (16), and 8 ([Nδ-(IGly)Orn8]degarelix, IC50 = 1.38 nM) (20) and N-methylation ([Nα-methyl-Leu7]degarelix, IC50 = 1.47 nM) (32) yielded analogues that were equipotent to degarelix (2) in vitro (IC50 = 1.64 nM) but shorter acting in vivo. Out of the 33 novel analogues tested for the duration of action in this series, two analogues ([Nε-cyclohexyl-Lys8]degarelix, IC50 = 1.50 nM) (23) and ([Nβ-(IβAla)Dap8]degarelix, IC50 = 1.98 nM) (26) had antagonist potencies and duration of action similar to that of azaline B {inhibited LH (>80%) release for >72 h after sc injection to castrated male rats at a standard dose of 50 μg/rat in 5% mannitol}. Under similar conditions analogues ([Nγ-(IGly)Dab8]degarelix, IC50 = 1.56 nM) (21) and ([IOrn8]degarelix, IC50 = 1.72 nM) (18) had a longer duration of action {inhibited LH (>96 h) release} than azaline B; however they were shorter acting than degarelix. Hydrophilicity of these analogues, a potential measure of their ability to be formulated for sustained release, was determined using RP-HPLC at neutral pH yielding analogues with shorter as well as longer retention times. No correlation was found between retention times and antagonist potency or duration of action.Keywords
This publication has 46 references indexed in Scilit:
- Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5Peptide Science, 2004
- Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures1The Journal of Organic Chemistry, 1996
- Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamineBiochemical and Biophysical Research Communications, 1987
- Effect of reductive alkylation of lysine in positions 6 and/or 8 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonistsJournal of Medicinal Chemistry, 1987
- Improved antagonists of luteinizing hormone-releasing hormone modified in position 7Journal of Medicinal Chemistry, 1985
- Isolation and characterization of chicken hypothalamic luteinizing hormone-releasing hormoneBiochemical and Biophysical Research Communications, 1982
- Luteinizing hormone-releasing hormone. Antiovulatory activity of analogs substituted in positions 2 and 6Journal of Medicinal Chemistry, 1975
- Analogs of luteinizing hormone releasing factor (LRF) synthesis and biological activity of [(Nα-Me)Leu7]LRF and [D-Ala6,(Nα-Me)Leu7]LRFBiochemical and Biophysical Research Communications, 1975
- 1339. Substituted diphenylmethyl protecting groups in peptide synthesisJournal of the Chemical Society (Resumed), 1965
- BOOK REVIEWSJournal of the American Chemical Society, 1953